Insights into elastic fiber fragmentation: Mechanisms and treatment of aortic aneurysm in Marfan syndrome
Vascular Pharmacology · 2023-12 · 153 · 107215
DOI: 10.1016/j.vph.2023.107215 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vascular Pharmacology, 2023-12. Verfasst von Sheilabi Seeburun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Wayne State University, Detroit, MI, USA. Hauptthemen laut MEDLINE: Marfan Syndrome, Aortic Aneurysm. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder caused by mutations in fibrillin 1 (FBN1) gene. These mutations result in defects in the skeletal, ocular, and cardiovascular systems. Aortic aneurysm is the leading cause of premature mortality in untreated MFS patients. Elastic fiber fragmentation in the aortic vessel wall is a hallmark of MFS-associated aortic aneurysms. FBN1 mutations result in FBN1 fragments that also contribute to elastic fiber fragmentation. Although recent research has advanced our understanding of MFS, the contribution of elastic fiber fragmentation to the pathogenesis of aneurysm formation remains poorly understood. This review provides a comprehensive overview of the molecular mechanisms of elastic fiber fragmentation and its role in the pathogenesis of aortic aneurysm progression. Increased comprehension of elastic fragmentation has significant clinical implications for developing targeted interventions to block aneurysm progression, which would benefit not only individuals with Marfan syndrome but also other patients with aneurysms. Moreover, this review highlights an overlooked connection between inhibiting aneurysm and the restoration of elastic fibers in the vessel wall with various aneurysm inhibitors, including drugs and chemicals. Investigating the underlying molecular mechanisms could uncover innovative therapeutic strategies to inhibit elastin fragmentation and prevent the progression of aneurysms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Wayne State University, Detroit, MI, USA.
- Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA.
- Department of Internal Medicine, Wayne State University, Detroit, MI, USA; Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA.
- Department of Internal Medicine, Wayne State University, Detroit, MI, USA; Department of Oncology, Wayne State University, Detroit, MI, USA.
- Department of Oncology, Wayne State University, Detroit, MI, USA.
- Department of Internal Medicine, Wayne State University, Detroit, MI, USA; Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA. Electronic address: lili@med.wayne.edu.
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Seeburun, S., Wu, S., Hemani, D., Pham, L., Ju, D., Xie, Y., Kata, P., & Li, L. (2023). Insights into elastic fiber fragmentation: Mechanisms and treatment of aortic aneurysm in Marfan syndrome. Vascular Pharmacology, 153, 107215. https://doi.org/10.1016/j.vph.2023.107215
Vancouver
Seeburun S, Wu S, Hemani D, Pham L, Ju D, Xie Y, et al. Insights into elastic fiber fragmentation: Mechanisms and treatment of aortic aneurysm in Marfan syndrome. Vascular Pharmacology. 2023;153:107215. doi:10.1016/j.vph.2023.107215
BibTeX
@article{Seeburun2023,
author = {Seeburun, Sheilabi and Wu, Shichao and Hemani, Darshi and Pham, Lucynda and Ju, Donghong and Xie, Youming and Kata, Priyaranjan and Li, Li},
title = {Insights into elastic fiber fragmentation: Mechanisms and treatment of aortic aneurysm in Marfan syndrome},
journal = {Vascular Pharmacology},
year = {2023},
volume = {153},
pages = {107215},
doi = {10.1016/j.vph.2023.107215}
}
EUVIMED